Skip to main content
Equibles

Alterity Therapeutics Data Presentations Support Advancement of ATH434 into Phase 3 in Multiple System Atrophy

Alterity Therapeutics Ltd (ATHE)

Capital Markets Day Call date: 2026-05-19 Concluded
Share

Report a Problem

Category
Description
Email (optional, for follow-up)